Mark B. Carter
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Single-cell and spatial transcriptomics 3
- RNA Interference and Gene Delivery 3
- PI3K/AKT/mTOR signaling in cancer 2
- Fungal and yeast genetics research 2
- Cancer therapeutics and mechanisms 2
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Larry A. Sklar (10 shared papers)Bryan Edwards (1 shared paper)Genevieve K Phillips (1 shared paper)Walker Wharton (1 shared paper)Carlee E. Ashley (1 shared paper)David S. Peabody (1 shared paper)Eric C. Carnes (1 shared paper)Paul N. Durfee (1 shared paper)
- Journals
- Cytometry Part A (2 papers)SLAS DISCOVERY (2 papers)Current Opinion in Pharmacology (1 paper)Nature Protocols (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- United StatesRomaniaSwitzerland
In The Last Decade
Mark B. Carter
19 papers receiving 1.5k citations
Mark B. Carter's Hit Papers
Peers
Comparison fields: 5 of 111
- Biomaterials 528
- Biomedical Engineering 549
- Molecular Biology 737
- Pharmaceutical Science 50
- Biophysics 43
Countries citing papers authored by Mark B. Carter
This map shows the geographic impact of Mark B. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Carter more than expected).
Fields of papers citing papers by Mark B. Carter
This network shows the impact of papers produced by Mark B. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Carter. The network helps show where Mark B. Carter may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark B. Carter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers Hit paper breakdown → | 2011 | 932 |
| 2 | 2011 | 305 | |
| 3 | 2007 | 66 | |
| 4 | 2013 | 53 | |
| 5 | 2007 | 33 | |
| 6 | 2012 | 22 | |
| 7 | 2011 | 22 | |
| 8 | 2011 | 21 | |
| 9 | 2012 | 19 | |
| 10 | 2016 | 18 | |
| 11 | 2014 | 17 | |
| 12 | 2012 | 17 | |
| 13 | 2011 | 11 | |
| 14 | 2014 | 10 | |
| 15 | Profiling a Selective Probe for RTG Branch of Yeast TORC1 Signaling Pathway | 2013 | 3 |
| 16 | 2018 | 2 | |
| 17 | 2015 | 2 | |
| 18 | Selective Efflux Inhibition of ATP-binding Cassette Sub-family G Member 2 | 2013 | 1 |
| 19 | 2005 | 1 |
About Mark B. Carter
Mark B. Carter is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Physiology and Anesthesiology and Pain Medicine, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Single-cell and spatial transcriptomics (3 papers), RNA Interference and Gene Delivery (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Microfluidic and Bio-sensing Technologies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Fungal and yeast genetics research (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Biomaterials (528 citations), Biomedical Engineering (549 citations), Molecular Biology (737 citations), Pharmaceutical Science (50 citations) and Biophysics (43 citations). Mark B. Carter has collaborated with scholars based in United States, Romania and Switzerland. Frequent co-authors include Larry A. Sklar, Bryan Edwards, Genevieve K Phillips, Walker Wharton, Carlee E. Ashley, David S. Peabody, Eric C. Carnes, Paul N. Durfee, Cheryl L. Willman and Christopher A. Lino. Their work appears in journals such as Cytometry Part A, SLAS DISCOVERY, Current Opinion in Pharmacology, Nature Protocols and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.